Test-retest, responsiveness, and minimal important change of the ability to perform physical activities of daily living questionnaire in individuals with type 2 diabetes and obesity

The Ability to Perform Physical Activities of Daily Living Questionnaire (APPADL) measures the self-reported ability of individuals with type 2 diabetes mellitus (T2DM) and obesity to perform daily physical activities. The primary objective of this study was to estimate APPADL test-retest reliabilit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes technology & therapeutics 2012-12, Vol.14 (12), p.1118-1125
Hauptverfasser: Hayes, Risa P, Schultz, Elisabeth M, Naegeli, April N, Curtis, Bradley H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1125
container_issue 12
container_start_page 1118
container_title Diabetes technology & therapeutics
container_volume 14
creator Hayes, Risa P
Schultz, Elisabeth M
Naegeli, April N
Curtis, Bradley H
description The Ability to Perform Physical Activities of Daily Living Questionnaire (APPADL) measures the self-reported ability of individuals with type 2 diabetes mellitus (T2DM) and obesity to perform daily physical activities. The primary objective of this study was to estimate APPADL test-retest reliability, responsiveness, and minimal important change (MIC). Study participants were individuals with T2DM and body mass index ≥30 kg/m(2) enrolled in clinical weight loss programs in the United States. Data were obtained for clinical measures, APPADL, and other patient-reported instruments. APPADL test-retest reliability was estimated with intraclass correlation coefficient. To estimate responsiveness in a subgroup of participants, baseline and 6-month data were analyzed using paired t test and calculation of responsiveness indices (e.g., effect size [ES]). To estimate MIC, both distribution-based and anchor-based methods were used. Test-retest data for 106 study participants (mean age, 52 years; 69% female; 31% white; mean body mass index, 38 kg/m(2)) yielded an intraclass correlation coefficient of 0.91. In the subgroup (n = 40) used to estimate responsiveness, weight was significantly less at end point than at baseline (mean, 222.0 vs. 231.9 pounds; P < 0.001, ES = 0.24), and APPADL scores were significantly better than at baseline (mean, 77.0 vs. 70.8; P = 0.01, ES = 0.32). Results of distribution- and anchor-based methods to establish MIC suggest values of 6-14 points (0-100 scale). The APPADL has demonstrated reliability and validity. In addition, it has demonstrated responsiveness to weight loss in individuals with T2DM and obesity, thereby making it a potentially valuable tool in the evaluation of weight loss interventions (e.g., antihyperglycemic medications that produce weight loss) targeted toward patients with T2DM.
doi_str_mv 10.1089/dia.2012.0123
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1237511754</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1237511754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-44aac0f087473b6996b40384d28157f019a7b4df57476d687ef441a9dc22aced3</originalsourceid><addsrcrecordid>eNo9kctu1TAQhi0EoqWwZItmyaI5-BonS1RxqVSJTVlHjj3pMUrsYPsU5cF4P5y2VLI1lueb60_Ie0YPjHb9J-fNgVPGD_WKF-ScKaWbTvXi5f7mtOmZas_Im5x_UUq14Ow1OeOCslYxdU7-3mIuTcJSzSUkzGsM2d9jwJwvwQQHiw9-MTP4ZY2pmFDAHk24Q4gTlCOCGf3sywYlwoppimmB9bhlb2uMscXf--Ix77Qzft5grj_hDn6fakUfQzA-IfhQj6sedzJzhj--HKFsKwKHOuC4t_fQTBwx12JvyaupcvjuyV6Qn1-_3F59b25-fLu--nzTWN6L0khpjKUT7bTUYmz7vh0lFZ10vGNKT5T1Ro_STar6W9d2Gicpmemd5dxYdOKCfHzMu6b40PCw-Gxxnk3AeMpDXblWjGklK9o8ojbFnBNOw5rq3tI2MDrsSg11kGFXatiVqvyHp9SncUH3TP-XRvwD40qTLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237511754</pqid></control><display><type>article</type><title>Test-retest, responsiveness, and minimal important change of the ability to perform physical activities of daily living questionnaire in individuals with type 2 diabetes and obesity</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Hayes, Risa P ; Schultz, Elisabeth M ; Naegeli, April N ; Curtis, Bradley H</creator><creatorcontrib>Hayes, Risa P ; Schultz, Elisabeth M ; Naegeli, April N ; Curtis, Bradley H</creatorcontrib><description>The Ability to Perform Physical Activities of Daily Living Questionnaire (APPADL) measures the self-reported ability of individuals with type 2 diabetes mellitus (T2DM) and obesity to perform daily physical activities. The primary objective of this study was to estimate APPADL test-retest reliability, responsiveness, and minimal important change (MIC). Study participants were individuals with T2DM and body mass index ≥30 kg/m(2) enrolled in clinical weight loss programs in the United States. Data were obtained for clinical measures, APPADL, and other patient-reported instruments. APPADL test-retest reliability was estimated with intraclass correlation coefficient. To estimate responsiveness in a subgroup of participants, baseline and 6-month data were analyzed using paired t test and calculation of responsiveness indices (e.g., effect size [ES]). To estimate MIC, both distribution-based and anchor-based methods were used. Test-retest data for 106 study participants (mean age, 52 years; 69% female; 31% white; mean body mass index, 38 kg/m(2)) yielded an intraclass correlation coefficient of 0.91. In the subgroup (n = 40) used to estimate responsiveness, weight was significantly less at end point than at baseline (mean, 222.0 vs. 231.9 pounds; P &lt; 0.001, ES = 0.24), and APPADL scores were significantly better than at baseline (mean, 77.0 vs. 70.8; P = 0.01, ES = 0.32). Results of distribution- and anchor-based methods to establish MIC suggest values of 6-14 points (0-100 scale). The APPADL has demonstrated reliability and validity. In addition, it has demonstrated responsiveness to weight loss in individuals with T2DM and obesity, thereby making it a potentially valuable tool in the evaluation of weight loss interventions (e.g., antihyperglycemic medications that produce weight loss) targeted toward patients with T2DM.</description><identifier>ISSN: 1520-9156</identifier><identifier>EISSN: 1557-8593</identifier><identifier>DOI: 10.1089/dia.2012.0123</identifier><identifier>PMID: 23016515</identifier><language>eng</language><publisher>United States</publisher><subject>Activities of Daily Living ; Adult ; Aged ; Body Mass Index ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - physiopathology ; Exercise ; Female ; Humans ; Male ; Middle Aged ; Mobility Limitation ; Obesity - epidemiology ; Obesity - physiopathology ; Obesity - prevention &amp; control ; Patient Compliance ; Prospective Studies ; Reproducibility of Results ; Surveys and Questionnaires ; United States - epidemiology ; Weight Loss ; Weight Reduction Programs</subject><ispartof>Diabetes technology &amp; therapeutics, 2012-12, Vol.14 (12), p.1118-1125</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c293t-44aac0f087473b6996b40384d28157f019a7b4df57476d687ef441a9dc22aced3</citedby><cites>FETCH-LOGICAL-c293t-44aac0f087473b6996b40384d28157f019a7b4df57476d687ef441a9dc22aced3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23016515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hayes, Risa P</creatorcontrib><creatorcontrib>Schultz, Elisabeth M</creatorcontrib><creatorcontrib>Naegeli, April N</creatorcontrib><creatorcontrib>Curtis, Bradley H</creatorcontrib><title>Test-retest, responsiveness, and minimal important change of the ability to perform physical activities of daily living questionnaire in individuals with type 2 diabetes and obesity</title><title>Diabetes technology &amp; therapeutics</title><addtitle>Diabetes Technol Ther</addtitle><description>The Ability to Perform Physical Activities of Daily Living Questionnaire (APPADL) measures the self-reported ability of individuals with type 2 diabetes mellitus (T2DM) and obesity to perform daily physical activities. The primary objective of this study was to estimate APPADL test-retest reliability, responsiveness, and minimal important change (MIC). Study participants were individuals with T2DM and body mass index ≥30 kg/m(2) enrolled in clinical weight loss programs in the United States. Data were obtained for clinical measures, APPADL, and other patient-reported instruments. APPADL test-retest reliability was estimated with intraclass correlation coefficient. To estimate responsiveness in a subgroup of participants, baseline and 6-month data were analyzed using paired t test and calculation of responsiveness indices (e.g., effect size [ES]). To estimate MIC, both distribution-based and anchor-based methods were used. Test-retest data for 106 study participants (mean age, 52 years; 69% female; 31% white; mean body mass index, 38 kg/m(2)) yielded an intraclass correlation coefficient of 0.91. In the subgroup (n = 40) used to estimate responsiveness, weight was significantly less at end point than at baseline (mean, 222.0 vs. 231.9 pounds; P &lt; 0.001, ES = 0.24), and APPADL scores were significantly better than at baseline (mean, 77.0 vs. 70.8; P = 0.01, ES = 0.32). Results of distribution- and anchor-based methods to establish MIC suggest values of 6-14 points (0-100 scale). The APPADL has demonstrated reliability and validity. In addition, it has demonstrated responsiveness to weight loss in individuals with T2DM and obesity, thereby making it a potentially valuable tool in the evaluation of weight loss interventions (e.g., antihyperglycemic medications that produce weight loss) targeted toward patients with T2DM.</description><subject>Activities of Daily Living</subject><subject>Adult</subject><subject>Aged</subject><subject>Body Mass Index</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Exercise</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mobility Limitation</subject><subject>Obesity - epidemiology</subject><subject>Obesity - physiopathology</subject><subject>Obesity - prevention &amp; control</subject><subject>Patient Compliance</subject><subject>Prospective Studies</subject><subject>Reproducibility of Results</subject><subject>Surveys and Questionnaires</subject><subject>United States - epidemiology</subject><subject>Weight Loss</subject><subject>Weight Reduction Programs</subject><issn>1520-9156</issn><issn>1557-8593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kctu1TAQhi0EoqWwZItmyaI5-BonS1RxqVSJTVlHjj3pMUrsYPsU5cF4P5y2VLI1lueb60_Ie0YPjHb9J-fNgVPGD_WKF-ScKaWbTvXi5f7mtOmZas_Im5x_UUq14Ow1OeOCslYxdU7-3mIuTcJSzSUkzGsM2d9jwJwvwQQHiw9-MTP4ZY2pmFDAHk24Q4gTlCOCGf3sywYlwoppimmB9bhlb2uMscXf--Ix77Qzft5grj_hDn6fakUfQzA-IfhQj6sedzJzhj--HKFsKwKHOuC4t_fQTBwx12JvyaupcvjuyV6Qn1-_3F59b25-fLu--nzTWN6L0khpjKUT7bTUYmz7vh0lFZ10vGNKT5T1Ro_STar6W9d2Gicpmemd5dxYdOKCfHzMu6b40PCw-Gxxnk3AeMpDXblWjGklK9o8ojbFnBNOw5rq3tI2MDrsSg11kGFXatiVqvyHp9SncUH3TP-XRvwD40qTLg</recordid><startdate>201212</startdate><enddate>201212</enddate><creator>Hayes, Risa P</creator><creator>Schultz, Elisabeth M</creator><creator>Naegeli, April N</creator><creator>Curtis, Bradley H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201212</creationdate><title>Test-retest, responsiveness, and minimal important change of the ability to perform physical activities of daily living questionnaire in individuals with type 2 diabetes and obesity</title><author>Hayes, Risa P ; Schultz, Elisabeth M ; Naegeli, April N ; Curtis, Bradley H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-44aac0f087473b6996b40384d28157f019a7b4df57476d687ef441a9dc22aced3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Activities of Daily Living</topic><topic>Adult</topic><topic>Aged</topic><topic>Body Mass Index</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Exercise</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mobility Limitation</topic><topic>Obesity - epidemiology</topic><topic>Obesity - physiopathology</topic><topic>Obesity - prevention &amp; control</topic><topic>Patient Compliance</topic><topic>Prospective Studies</topic><topic>Reproducibility of Results</topic><topic>Surveys and Questionnaires</topic><topic>United States - epidemiology</topic><topic>Weight Loss</topic><topic>Weight Reduction Programs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hayes, Risa P</creatorcontrib><creatorcontrib>Schultz, Elisabeth M</creatorcontrib><creatorcontrib>Naegeli, April N</creatorcontrib><creatorcontrib>Curtis, Bradley H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes technology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hayes, Risa P</au><au>Schultz, Elisabeth M</au><au>Naegeli, April N</au><au>Curtis, Bradley H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Test-retest, responsiveness, and minimal important change of the ability to perform physical activities of daily living questionnaire in individuals with type 2 diabetes and obesity</atitle><jtitle>Diabetes technology &amp; therapeutics</jtitle><addtitle>Diabetes Technol Ther</addtitle><date>2012-12</date><risdate>2012</risdate><volume>14</volume><issue>12</issue><spage>1118</spage><epage>1125</epage><pages>1118-1125</pages><issn>1520-9156</issn><eissn>1557-8593</eissn><abstract>The Ability to Perform Physical Activities of Daily Living Questionnaire (APPADL) measures the self-reported ability of individuals with type 2 diabetes mellitus (T2DM) and obesity to perform daily physical activities. The primary objective of this study was to estimate APPADL test-retest reliability, responsiveness, and minimal important change (MIC). Study participants were individuals with T2DM and body mass index ≥30 kg/m(2) enrolled in clinical weight loss programs in the United States. Data were obtained for clinical measures, APPADL, and other patient-reported instruments. APPADL test-retest reliability was estimated with intraclass correlation coefficient. To estimate responsiveness in a subgroup of participants, baseline and 6-month data were analyzed using paired t test and calculation of responsiveness indices (e.g., effect size [ES]). To estimate MIC, both distribution-based and anchor-based methods were used. Test-retest data for 106 study participants (mean age, 52 years; 69% female; 31% white; mean body mass index, 38 kg/m(2)) yielded an intraclass correlation coefficient of 0.91. In the subgroup (n = 40) used to estimate responsiveness, weight was significantly less at end point than at baseline (mean, 222.0 vs. 231.9 pounds; P &lt; 0.001, ES = 0.24), and APPADL scores were significantly better than at baseline (mean, 77.0 vs. 70.8; P = 0.01, ES = 0.32). Results of distribution- and anchor-based methods to establish MIC suggest values of 6-14 points (0-100 scale). The APPADL has demonstrated reliability and validity. In addition, it has demonstrated responsiveness to weight loss in individuals with T2DM and obesity, thereby making it a potentially valuable tool in the evaluation of weight loss interventions (e.g., antihyperglycemic medications that produce weight loss) targeted toward patients with T2DM.</abstract><cop>United States</cop><pmid>23016515</pmid><doi>10.1089/dia.2012.0123</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1520-9156
ispartof Diabetes technology & therapeutics, 2012-12, Vol.14 (12), p.1118-1125
issn 1520-9156
1557-8593
language eng
recordid cdi_proquest_miscellaneous_1237511754
source MEDLINE; Alma/SFX Local Collection
subjects Activities of Daily Living
Adult
Aged
Body Mass Index
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - physiopathology
Exercise
Female
Humans
Male
Middle Aged
Mobility Limitation
Obesity - epidemiology
Obesity - physiopathology
Obesity - prevention & control
Patient Compliance
Prospective Studies
Reproducibility of Results
Surveys and Questionnaires
United States - epidemiology
Weight Loss
Weight Reduction Programs
title Test-retest, responsiveness, and minimal important change of the ability to perform physical activities of daily living questionnaire in individuals with type 2 diabetes and obesity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T13%3A48%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Test-retest,%20responsiveness,%20and%20minimal%20important%20change%20of%20the%20ability%20to%20perform%20physical%20activities%20of%20daily%20living%20questionnaire%20in%20individuals%20with%20type%202%20diabetes%20and%20obesity&rft.jtitle=Diabetes%20technology%20&%20therapeutics&rft.au=Hayes,%20Risa%20P&rft.date=2012-12&rft.volume=14&rft.issue=12&rft.spage=1118&rft.epage=1125&rft.pages=1118-1125&rft.issn=1520-9156&rft.eissn=1557-8593&rft_id=info:doi/10.1089/dia.2012.0123&rft_dat=%3Cproquest_cross%3E1237511754%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1237511754&rft_id=info:pmid/23016515&rfr_iscdi=true